Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis

PHASE4CompletedINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Thrombosis
Interventions
DRUG

Desirudin

Desirudin SC 15mg q12h

Trial Locations (16)

10065

Weill Cornell Medical College, New York

24014

Carilion Roanoke Memorial Hospital, Roanoke

27103

Forsyth Regional Medical Center, Winston-Salem

30033

Southeastern Center for Clinical Trials, Decatur

30342

Saint Joseph's Research Institute, Atlanta

33606

University of South Florida, Tampa General Hospital, Tampa

43210

The Ohio State University Medical Center, Columbus

55902

Forsyth Regional Medical Center, Winston-Salem

60435

Provena St. Joseph's Medical Center, Joliet

61606

Illinois Lung and Critical Care Institute, Peoria

63141

St. John's Mercy Medical Center, St Louis

77024

Research Concepts, Memorial Hermann Healthcare System, Houston

80045

University of Colorado Health Science Center, Aurora

07901

Overlook Hospital, Summit

11794-8191

Stony Brook University Medical Center, Stony Brook

19102-1192

Drexel University College of Medicine, Philadelphia

Sponsors
All Listed Sponsors
lead

Canyon Pharmaceuticals, Inc.

INDUSTRY